Methimazole and Theophylline drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Methimazole and Theophylline. Common interactions include bronchitis among females and cerebrovascular accident among males.

The phase IV clinical study analyzes what interactions people who take Methimazole and Theophylline have. It is created by eHealthMe based on reports of 12 people who take Methimazole and Theophylline from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Sep, 18, 2023

12 people who take Methimazole and Theophylline together, and have interactions are studied.

What is Methimazole?

Methimazole has active ingredients of methimazole. It is often used in hyperthyroidism. eHealthMe is studying from 7,129 Methimazole users for its effectiveness, alternative drugs and more.

What is Theophylline?

Theophylline has active ingredients of theophylline. It is often used in asthma. eHealthMe is studying from 18,521 Theophylline users for its effectiveness, alternative drugs and more.

Number of Methimazole and Theophylline reports submitted per year:

Common Methimazole and Theophylline drug interactions by gender *:

female:

Bronchitis
Cerebral haemorrhage
Chills
Depression
Drug hypersensitivity
Hypoaesthesia
Injury
Neuropathy peripheral
Pain
Pain in extremity

male:

Cerebrovascular accident
Dysarthria
Respiratory failure
Klebsiella infection
Hemiparesis
Loss of proprioception
Candida pneumonia
Enterobacter pneumonia
Lung disorder
Pneumonia klebsiella

Common Methimazole and Theophylline drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

Candida pneumonia
Enterobacter pneumonia
Lung disorder
Pneumonia klebsiella
Pulmonary toxicity
Pyrexia
Respiratory failure
Klebsiella infection

Common conditions people have *:

High Blood Pressure: 3 people, 25.00%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 3 people, 25.00%
Type 2 Diabetes: 1 person, 8.33%
Sinusitis (inflammation of sinus): 1 person, 8.33%
Diverticulitis (digestive disease which involves the formation of pouches (diverticula) within the bowel wall): 1 person, 8.33%
Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Methimazole and Theophylline?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Korang-Yeboah M, Rahman Z, Shah D, Mohammad A, Wu S, Siddiqui A, Khan MA, "Impact of formulation and process variables on solid-state stability of theophylline in controlled release formulations", International journal of pharmaceutics, 2016 Feb .
Dhaval MK, "Impact of formulation and process variables on solid-state stability of theophylline in controlled release formulations", International Journal of Pharmaceutics, 2016 Jan .